GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $223,000 | -3.9% | 5,300 | -11.8% | 0.06% | -11.6% |
| Q4 2016 | $232,000 | -78.3% | 6,012 | -75.7% | 0.07% | -78.3% |
| Q3 2016 | $1,067,000 | +33.5% | 24,737 | +34.2% | 0.32% | +22.3% |
| Q2 2016 | $799,000 | +21.6% | 18,437 | +13.7% | 0.26% | +0.4% |
| Q1 2016 | $657,000 | +12.7% | 16,212 | +12.3% | 0.26% | +24.5% |
| Q4 2015 | $583,000 | +16.8% | 14,437 | +11.2% | 0.21% | +12.4% |
| Q3 2015 | $499,000 | -19.5% | 12,987 | -12.7% | 0.18% | -13.1% |
| Q2 2015 | $620,000 | +6.9% | 14,880 | +18.3% | 0.21% | +6.0% |
| Q1 2015 | $580,000 | +2421.7% | 12,577 | +2242.1% | 0.20% | +2412.5% |
| Q4 2014 | $23,000 | -45.2% | 537 | -41.2% | 0.01% | -50.0% |
| Q3 2014 | $42,000 | +31.2% | 914 | +53.1% | 0.02% | +33.3% |
| Q2 2014 | $32,000 | +10.3% | 597 | +11.2% | 0.01% | +9.1% |
| Q1 2014 | $29,000 | 0.0% | 537 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $29,000 | +7.4% | 537 | 0.0% | 0.01% | -8.3% |
| Q3 2013 | $27,000 | -27.0% | 537 | -27.1% | 0.01% | -33.3% |
| Q2 2013 | $37,000 | – | 737 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |